Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to -$8.7 million.

  • LifeMD's Cash from Financing Activities fell 55884.55% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.6 million, marking a year-over-year decrease of 22125.42%. This contributed to the annual value of -$4.1 million for FY2024, which is 11415.31% down from last year.
  • LifeMD's Cash from Financing Activities amounted to -$8.7 million in Q3 2025, which was down 55884.55% from -$3.1 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Cash from Financing Activities ranged from a high of $39.3 million in Q4 2021 and a low of -$8.7 million during Q3 2025
  • Over the past 5 years, LifeMD's median Cash from Financing Activities value was -$774063.0 (recorded in 2022), while the average stood at $4.2 million.
  • Per our database at Business Quant, LifeMD's Cash from Financing Activities skyrocketed by 164915.89% in 2023 and then plummeted by 55884.55% in 2025.
  • LifeMD's Cash from Financing Activities (Quarter) stood at $39.3 million in 2021, then plummeted by 95.26% to $1.9 million in 2022, then skyrocketed by 671.21% to $14.4 million in 2023, then tumbled by 106.51% to -$934903.0 in 2024, then plummeted by 830.68% to -$8.7 million in 2025.
  • Its Cash from Financing Activities stands at -$8.7 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$812563.0 for Q1 2025.